Literature DB >> 25568069

The human IgG anti-carbohydrate repertoire exhibits a universal architecture and contains specificity for microbial attachment sites.

Christoph Schneider1, David F Smith2, Richard D Cummings2, Kayluz Frias Boligan1, Robert G Hamilton3, Bruce S Bochner3, Sylvia Miescher4, Hans-Uwe Simon1, Anastas Pashov5, Tchavdar Vassilev5, Stephan von Gunten6.   

Abstract

Despite the paradigm that carbohydrates are T cell-independent antigens, isotype-switched glycan-specific immunoglobulin G (IgG) antibodies and polysaccharide-specific T cells are found in humans. We used a systems-level approach combined with glycan array technology to decipher the repertoire of carbohydrate-specific IgG antibodies in intravenous and subcutaneous immunoglobulin preparations. A strikingly universal architecture of this repertoire with modular organization among different donor populations revealed an association between immunogenicity or tolerance and particular structural features of glycans. Antibodies were identified with specificity not only for microbial antigens but also for a broad spectrum of host glycans that serve as attachment sites for viral and bacterial pathogens and/or exotoxins. Tumor-associated carbohydrate antigens were differentially detected by IgG antibodies, whereas non-IgG2 reactivity was predominantly absent. Our study highlights the power of systems biology approaches to analyze immune responses and reveals potential glycan antigen determinants that are relevant to vaccine design, diagnostic assays, and antibody-based therapies.
Copyright © 2015, American Association for the Advancement of Science.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25568069      PMCID: PMC4864610          DOI: 10.1126/scitranslmed.3010524

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN: 1946-6234            Impact factor:   17.956


  63 in total

Review 1.  Intravenous immunoglobulin: exploiting the potential of natural antibodies.

Authors:  Srini V Kaveri
Journal:  Autoimmun Rev       Date:  2012-02-12       Impact factor: 9.754

2.  Induction of natural autoantibody activity following treatment of human immunoglobulin with dissociating agents.

Authors:  J P Bouvet; D Stahl; S Rose; C P Quan; M D Kazatchkine; S V Kaveri
Journal:  J Autoimmun       Date:  2001-03       Impact factor: 7.094

Review 3.  Carbohydrate vaccines: developing sweet solutions to sticky situations?

Authors:  Rena D Astronomo; Dennis R Burton
Journal:  Nat Rev Drug Discov       Date:  2010-04       Impact factor: 84.694

4.  Intravenous immunoglobulin preparations contain anti-Siglec-8 autoantibodies.

Authors:  Stephan von Gunten; Monique Vogel; Alexander Schaub; Beda M Stadler; Sylvia Miescher; Paul R Crocker; Hans-Uwe Simon
Journal:  J Allergy Clin Immunol       Date:  2007-03-02       Impact factor: 10.793

Review 5.  Systems vaccinology.

Authors:  Bali Pulendran; Shuzhao Li; Helder I Nakaya
Journal:  Immunity       Date:  2010-10-29       Impact factor: 31.745

6.  Crystal structure of cholera toxin B-pentamer bound to receptor GM1 pentasaccharide.

Authors:  E A Merritt; S Sarfaty; F van den Akker; C L'Hoir; J A Martial; W G Hol
Journal:  Protein Sci       Date:  1994-02       Impact factor: 6.725

7.  Carbohydrate moieties as vaccine candidates: targeting the sweet spot in the immune response.

Authors:  Christopher E Taylor; Brian A Cobb; Kate Rittenhouse-Olson; James C Paulson; John R Schreiber
Journal:  Vaccine       Date:  2012-05-08       Impact factor: 3.641

8.  Molecular mimicry of host sialylated glycans allows a bacterial pathogen to engage neutrophil Siglec-9 and dampen the innate immune response.

Authors:  Aaron F Carlin; Satoshi Uchiyama; Yung-Chi Chang; Amanda L Lewis; Victor Nizet; Ajit Varki
Journal:  Blood       Date:  2009-02-04       Impact factor: 22.113

9.  Polysaccharide processing and presentation by the MHCII pathway.

Authors:  Brian A Cobb; Qun Wang; Arthur O Tzianabos; Dennis L Kasper
Journal:  Cell       Date:  2004-05-28       Impact factor: 41.582

10.  A mechanism for glycoconjugate vaccine activation of the adaptive immune system and its implications for vaccine design.

Authors:  Fikri Y Avci; Xiangming Li; Moriya Tsuji; Dennis L Kasper
Journal:  Nat Med       Date:  2011-11-20       Impact factor: 53.440

View more
  38 in total

1.  The Potential Role of Solvation in Antibody Recognition of the Lewis Y Antigen.

Authors:  Somdutta Saha; Ramachandran Murali; Anastas Pashov; Thomas Kieber-Emmons
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2015-10

2.  "Stuck on sugars - how carbohydrates regulate cell adhesion, recognition, and signaling".

Authors:  Richard D Cummings
Journal:  Glycoconj J       Date:  2019-07-02       Impact factor: 2.916

3.  Activity of MUC1 cancer antigen-binding plasma anti-α-galactoside antibody correlates inversely with size of autologous lipoprotein(a).

Authors:  Jessy John; Vasantha Kalaivani; Mandagini Geetha; Padinjaradath S Appukuttan
Journal:  Exp Biol Med (Maywood)       Date:  2019-08

4.  Antibody repertoire profiling with mimotope arrays.

Authors:  Shina Pashova; Christoph Schneider; Stephan von Gunten; Anastas Pashov
Journal:  Hum Vaccin Immunother       Date:  2016-12-08       Impact factor: 3.452

5.  Identification of pathogenic bacteria in human blood using IgG-modified Fe3O4 magnetic beads as a sorbent and MALDI-TOF MS for profiling.

Authors:  Jia Yi; Qin Qin; Yan Wang; Rutan Zhang; Hongyan Bi; Shaoning Yu; Baohong Liu; Liang Qiao
Journal:  Mikrochim Acta       Date:  2018-11-10       Impact factor: 5.833

6.  Gut immunoglobulin alpha anti-glycan binding profiles as a research tool for local disease detection.

Authors:  Joseph J Otto; Crystal L Daniels; Lindsay N Schambeau; Brittany N Williams; Jana M Rocker; Lewis K Pannell
Journal:  Glycoconj J       Date:  2018-06-09       Impact factor: 2.916

7.  Microbe-focused glycan array screening platform.

Authors:  Andreas Geissner; Anika Reinhardt; Christoph Rademacher; Timo Johannssen; João Monteiro; Bernd Lepenies; Michel Thépaut; Franck Fieschi; Jana Mrázková; Michaela Wimmerova; Frank Schuhmacher; Sebastian Götze; Dan Grünstein; Xiaoqiang Guo; Heung Sik Hahm; Jeyakumar Kandasamy; Daniele Leonori; Christopher E Martin; Sharavathi G Parameswarappa; Sandip Pasari; Mark K Schlegel; Hidenori Tanaka; Guozhi Xiao; You Yang; Claney L Pereira; Chakkumkal Anish; Peter H Seeberger
Journal:  Proc Natl Acad Sci U S A       Date:  2019-01-22       Impact factor: 11.205

8.  The architecture of the IgG anti-carbohydrate repertoire in primary antibody deficiencies.

Authors:  Peter Jandus; Kayluz Frias Boligan; David F Smith; Elisabeth de Graauw; Bodo Grimbacher; Camilla Jandus; Mai M Abdelhafez; Alain Despont; Nicolai Bovin; Dagmar Simon; Robert Rieben; Hans-Uwe Simon; Richard D Cummings; Stephan von Gunten
Journal:  Blood       Date:  2019-11-28       Impact factor: 22.113

Review 9.  "Siglec"ting the allergic response for therapeutic targeting.

Authors:  Bruce S Bochner
Journal:  Glycobiology       Date:  2016-02-23       Impact factor: 4.313

Review 10.  Manipulation of the glycan-specific natural antibody repertoire for immunotherapy.

Authors:  J Stewart New; R Glenn King; John F Kearney
Journal:  Immunol Rev       Date:  2016-03       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.